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Little is known regarding the functional role of nestin and its regulation. 42 A cytoskeletal polymer, nestin interacts with major elements of the cytoskeleton 30 and appears to lend structural support during development and in the process of cellular remodeling. 30 Nestin forms heterodimers and mixed polymers mainly with vimentin and ␣-internexin 30, 42 and is subsequently replaced by more tissue-specific intermediate filaments. 30 Phosphorylation of nestin derives disassembly of nestin polymers in processes that require cytoplasmic plasticity and during dynamic remodeling of cells such as in mitosis. 13, 30 Nitric oxide synthase-deficient mice demonstrate decreased nestin expression following CNS injury, thus implicating nitric oxide synthase in regulation of nestin expression. 10 In a previous study, we demonstrated that nontumorous J Neurosurg 108:118-123, 2008 Immunohistochemical expression of nestin in adenohypophysial vessels during development of pituitary infarction and adenomatous adenohypophysial cells were immunonegative for nestin. 46 Our results also showed nestin expression in types of endothelial cells, several pituitary adenoma endothelial cells, as well as of vessels growing into infarcted tissue. To characterize nestin expression during development and progression of pituitary infarcts in greater depth, we investigated adenohypophyses in patients with both frank pituitary apoplexy and focal adenohypophyses or tumoral infarction.
Materials and Methods
Forty-five nontumoral adenohypophyses and 34 pituitary adenomas, all exhibiting acute or healing infarcts were included in the study. The adenomas were obtained at surgery from patients with a clinical or pathological diagnosis of pituitary infarction/apoplexy. These included 5 growth hormone-producing adenomas, 7 prolactin-producing adenomas, 10 adrenocorticotropic hormone-secreting adenomas, 4 gonadotroph hormone-producing adenomas, 4 Type I silent corticotroph adenomas, and 4 oncocytomas. The 45 nontumoral specimens were obtained at autopsy and showed varying degrees of adenohypophysial necrosis. All specimens were fixed in 10% buffered formalin, routinely processed, paraffin embedded, cut at 4-6 m, and stained with H & E. Immunostaining used the streptavidinbiotin-peroxidase complex method and antisera directed against growth hormone, prolactin, adrenocorticotrophic hormone, thyroidstimulating hormone, luteinizing hormone, follicle-stimulating hormone, and ␣ subunit. In many surgical cases, electron microscopy had been performed for diagnosis on primarily fixed, routinely processed tissues.
Immunostaining of nestin used rabbit polyclonal antibody (IBL Gunma, 1:50 dilution). For VEGF immunostaining the rabbit polyclonal VEGF antibody (Santa Cruz Biotechnology, 1:100 dilution) was used. Routine deparaffinization, rehydration, and blockade of endogenous peroxidase activity were performed. Sections were then microwaved in 0.1 mM sodium citrate buffer (pH 6.0), incubated with goat antiserum, and subsequently exposed to the streptavidin-biotin-peroxidase complex. Diaminobenzidine served as the chromogen. For positive control of nestin immunoreactivity, formalin-fixed, paraffin-embedded gliomas and glioblastomas were used. Formalin-fixed, paraffin-embedded placental sections served as VEGF-positive controls. Replacement of the primary antibody with phosphate-buffered saline served as a negative control. The details of immunostaining methods have been previously described. 52, 54 By light microscopy, all sections were examined focusing upon areas of necrosis. Nestin immunopositivity in and around the necrotic areas was evaluated using high magnification (ϫ 400).
Results
By light microscopy, both nontumorous adenohypophyses and pituitary adenomas variably exhibited the following: focal, early infarcts; massive, acute necrosis ( Fig. 1A and B ); healing infarcts; and hypocellular, fibrotic scar tissue.
In normal adenohypophysial tissue and fragments of pituitary adenoma lacking infarction, nestin immunoexpression was apparent only in scattered capillaries and endothelial cells. Areas of acute infarction observed in 30 nontumorous specimens and in 20 adenomas were devoid of capillaries; no nestin immunopositivity was demonstrable (Fig. 1B) . Necrotic areas were characterized by loss of cell borders and nuclei on detail, as well as hemorrhage. Organizing infarcts differed entirely. Nestin immunoreactivity was evident in vessels growing into the periphery of necrotic zones in 15 nontumorous adenohypophyses and 10 adenomas. Endothelial cells in these formative blood vessels were strongly immunopositive for nestin ( Fig. 1C  and D) . In all adenomas featuring pituitary infarcts with granulation tissue and fibrosis (4 cases), blood vessels were fewer in number and showed only focal, mild nestin staining. These lesions were, in part, hypocellular with evident formation of fibrotic tissue.
In terms of nestin expression pattern, no significant differences were observed between pituitary apoplexy in nontumorous pituitaries and adenomas. Both featured new vessels growing into healing infarcts; the infarcted areas also exhibited similar histological features. Slight VEGF immunopositivity was noted in endothelial cells of the newly formed vessels in the periphery of necrotic zones.
Discussion
The present study is the first to demonstrate that following pituitary apoplexy and infarction no nestin expression is apparent in the necrotic capillaries, strong nestin immunoreactivity is evident in endothelial cells of newly growing vessels that demarcate the border of infarcted areas, and nestin immunoreactivity is subsequently downregulated in scar formation and fibrosis. Nestin expression is implicated in angiogenesis following injury, 32,33,38,43,44,54 but its expression in pituitary apoplexy and infarction has not been investigated to date. Pituitary wound healing is an under-researched area, and factors affecting the process remain largely unknown. As in other organs, pituitary wound healing is associated with angiogenesis, the formation of new blood vessels from existing vasculature. Although the concept of angiogenesis has been described in the context of various tissues, it has not as yet been characterized in pituitary infarction. Transient nestin expression has been associated with angiogenesis during the wound healing process in several settings. 32, 33, 38, 43, 44, 54 Nestin expression in the pituitary was first reported by Amoh et al. [3] [4] [5] who showed that its expression in the normal rat pituitary was in undifferentiated, nonhormone producing cells in proximity to endothelium. These characteristics, combined with high proliferative activity and motility in vitro suggested a pericyte phenotype. More recent evidence suggests that nestin is almost exclusively expressed in a newly discovered side population of cells in the pituitary that exhibit stem cell/ progenitor properties. 11 The cells in this side population are capable of clonal expansion, and in addition to nestin, express signaling molecules generally associated with stem/ progenitor cells. 11, 37 Thus it may be that nestin-expressing pituitary stem/progenitor cells play a role in the initiation of angiogenesis that follows pituitary infarction and that later in the fibrotic phase these stem cells differentiate.
Nestin expression in reparative processes is well known. For example, wound healing and scar formation in the CNS have been found to be associated with upregulation of nestin in reactive astrocytes and in endothelial as well as preendothelial cells. 14, 19, 22, 26, 32, 33, 38 In addition, vascularization of myocardial infarcts involves colonization of the damaged region by the migrating, nestin-expressing neural stem cells.
18, 43 Not surprisingly, Mokry et al. 43 reported nestin immunopositivity in the newly formed blood vessels of the fetus, corpus luteum, and healing myocardial infarcts, as well as in growing brain tumors. Nestin expression during neovascularization and active angiogenesis has also been documented in pancreatic regeneration 2, 29, 33 and in remodeling after CNS injury, 51 as well as in hematomas. 49 Nestin expression may result in the production of trophic angiogenic mediators 19 or, alternatively, it may simply be involved in providing cellular structural support and organization. 12 In support of the latter are the observations that in differentiated podocytes of adult renal glomeruli, nestin plays a role in maintaining structural integrity; 12 and in the CNS, nestin may affect glial cells, specifically the formation of their cytoskeleton and processes, and the formation of new synaptic connections in neurons. 54, 57 Recently, nestin expression in tumor angiogenesis was visualized using nestin-GFP transgenic nude mice orthotopically transplanted with tumors expressing RFP. 6 Using RFP-labeled melanoma transplants, Amoh et al. 6 showed that blood vessels in wound healing originate from nestinpositive hair follicles. Thus, nestin may be a marker of stem cells giving rise to proliferating endothelial cells. The expression of nestin in a stem cell-like side population in the pituitary provides further support for this theory.
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A key aspect of our findings was the transient expression of nestin in necrotic pituitary, primarily in newly formed vessels present in the proliferative phase healing process followed by downregulation in the organization phase. These observations are in keeping with most reports of temporal nestin expression in healing wounds 19, 32, 33, 38, 43, 44 and its diminution during the fibrotic phase, supporting a role for nestin during early active endothelial cell proliferation and angiogenesis. Indeed, most studies report transient nestin expression only in actively proliferating endothelial cells. 10, 26, 43, 49, 51 An experimental model has also underscored the occurrence of nestin expression during endothelial proliferation and its downregulation with differentiation. 8 The authors found bovine aortic endothelial cells in static culture to display strong nestin immunoreactivity and loss of this reactivity on exposure to shear stress flow and endothelial differentiation, 8 thus indicating that nestin expression is associated with an immature pheno-type. 36 Lastly, these same investigators found nestin expression in the vasculature of pulmonary, gastric, colon, and cervical carcinomas to be transient, disappearing with differentiation. 36 An alternative explanation for transient nestin expression in healing wounds is that nestin-positive cells eventually transdifferentiate, acquiring a different functional/structural phenotype. 36 For example, in tissue fibrosis following injury, pancreatic stellate cells transdifferentiate to myofibroblasts producing collagen as well as other extracellular matrix elements, mediators of inflammation, and growth factors. 36 Recently, a new role for nestin in malignant neuroblastoma cells was proposed. 53 Nestin was present in the nuclei of neuroblastoma cells that amplified the N-myc gene. Thus nestin may be a mediator of N-myc-associated tumor aggressiveness of human neuroblastoma. Whether nestin participates in N-myc-mediated signaling pathways in the pituitary remains to be investigated.
Another characteristic pattern of nestin expression in the present study is peripheral demarcation of necrotic zones by nestin-immunopositive vessels. Most studies of nestin expression in ischemic brain tissue also have reported this pattern of nestin expression immunoreactivity residing in astrocytes forming a narrow rim around zones of infarction, 8 ,32,38,48 a pattern closely associated with angiogenesis and the blood-brain barrier. 38 It is of note that VEGF mRNA expression in tumors with significant necrosis is also increased at the border of zones of necrosis. 63 Our results also demonstrated immunohistochemical expression of VEGF in these areas. It is notable that 1) folliculostellate cells are present in increased numbers at the boundary of pituitary adenomas, the likely site of angiogenic initiation, 59 as opposed to the adenoma core; and 2) VEGF expression in these folliculostellate cells increased in a similar distribution. 59 The underlying factors stimulating nestin expression in these various settings are unclear but may reflect microenvironmental cues that, in conjunction with genes activated following trauma, upregulate nestin expression in endothelial cells, reactive astrocytes, folliculostellate cells, and stem/progenitor cells. 2, 17, 60 Nestin is a stem cell marker at a number of sites, including the CNS, pancreas, testis, and heart. 61 The angiogenic potential of stem cells is well documented in various stages of angiogenesis. 24 It is intriguing that a newly discovered pituitary cell side population with stem/progenitor cell properties expresses nestin abundantly.
11 Nestin-positive pericytes in adult CNS microvasculature have multipotential stem cell properties, including neuronal potential in vitro, 34 and may be a source of stem cells at this site. In the testes, vascular smooth-muscle cells and pericytes expressing nestin are the progenitors of Leydig cells, 40 thus underscoring their multipotential nature. Nestin mRNA levels in rat myocardial vessels increase in response to myocardial ischemia; this increase is associated with cardiac neuronal stem cell migration to the injured site and subsequent resultant innervation of the scar. 18 In a similar way, Kupatt et al. 35 showed that embryonic endothelial progenitor cells provide functional protection in ischemic rabbit hindlimbs and in mouse myocardium by inducing neovascularization. If stem cells are present in the pituitary, they may provide the basis for novel therapeutic options. The exact lineage of the nestin-positive cells occurring in the pituitary remains to be elucidated, 11, 34 but it may well be that they are either pericytes or stem/progenitor cells, given the ability of a nestin-expressing side population in the pituitary to form clonal spheres. Under physiological conditions, angiogenesis is restricted to normal growth, wound healing, and cyclic alterations in the female reproductive system. 7 Angiogenesis also occurs in various pathological conditions, including diabetic retinopathy, ischemic heart disease, and tumor progression. 3, 9, 16, 20, 25, 27, 29, 39, 41, 62 Growth of solid tumors depends on angiogenesis for nutrient/oxygen supply and waste removal. Angiogenesis in the setting of neoplasia also facilitates metastasis and is associated with a poor clinical outcome. 16, 25, 27, 41 In contrast to tumors arising in various other tissues, microvascular density in adenohypophysial tumors is lower than that of the normal pituitary.
39,63 A function of angiogenic inhibitors has been demonstrated in pituitary tumors, 16, 59 thus treatment with angiogenesis inhibitors may prove useful in the management of adenomas nonresponsive to available therapy (for example, prolactinomas that do not respond to dopamine agonists). Invasive prolactinomas have a higher microvascular density than other pituitary adenomas. The same is true of thyrotroph adenomas and pituitary carcinomas. 16 Such tumors may be candidates for antiangiogenic therapy. In an experimental model, inhibitory effects of gemcitabine on pancreatic tumor angiogenesis and doxorubicin on melanoma angiogenesis have been visualized and evaluated using nestin-GFP nude mice orthotopically implanted with cell lines of both tumors 6,24,36 expressing RFP. As it is well established that formation of blood vessels is essential for tumorigenesis in most tissues, such studies have important implications in development of novel therapeutics. The antiangiogenic potential of gemcitabine has been demonstrated in several clinical studies 6 and was found to be associated with decreased serum VEGF levels in patients with locally advanced and metastatic tumors. In summary, nestin may be a novel target; given that intron 1 of the nestin gene is implicated in its neovascularization efforts, modalities that target this intron may prove beneficial in the management of particularly vascular tumors. 1 The regulation of nestin expression and its polymerization are not well understood. The kinase Cdk5 phosphorylates nestin and may be associated with disassembly of this intermediate filament during development and proliferation. 13, 30 Whereas tissue-specific expression of nestin in neuronal stem cells is regulated by the second intron of the nestin gene, its endothelial expression in tumors is regulated by the first intron.
1 A better understanding of factors involved in transient nestin expression during angiogenesis and wound healing may have important implications in pituitary stem cell research and development of novel therapeutic modalities. 
